Background Interpretation of differences or changes in patient-reported outcome scores
should not only consider statistical significance, but also clinical relevance. Accordingly, …

… C, followed by 40 repeated cycles of 95 C for 10 s and 60 C for 30 s. Melting curves were
investigated by increasing the temperature from 55 C to 90 C with a plate reading every 0.2 C. …

To our knowledge, this is the first comprehensive study on the influence of several pre-analytical
and demographic parameters that could be a source of variability in the quantification of …

Simple Summary HER2-low breast cancer is an emerging subtype for which very few data
are available, especially within the triple-negative breast cancer (TNBC) group. Our aim was …

Evidence suggests that lean body mass (LBM) may be useful to normalize chemotherapy
doses. Data from one prospective and one retrospective study were used to determine if the …

Background While tumor-tissue remains the ‘gold standard’ for genetic analysis in cancer
patients, it is challenged with the advent of circulating cell-free tumor DNA (ctDNA) analysis …

The antiestrogen tamoxifen, a major endocrine therapy of estrogen receptor (ER)-positive
breast cancer, is nevertheless inefficient in 30 to 40% of cases for unknown reasons. We …

Background Classical phase 1 dose-finding designs based on a single toxicity endpoint to
assess the maximum tolerated dose were initially developed in the context of cytotoxic drugs. …

… The quantification of nilotinib anti‐invasive activity in HCT116 cells is shown in panel (C). …
(C) Invasion assays in Boyden chambers of the indicated cell lines after incubation with DMSO …

Background Currently, metastatic colorectal cancer is treated as a homogeneous disease
and only RAS mutational status has been approved as a negative predictive factor in patients …